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A B S T R A C T
Malaria is a parasitic disease of which Plasmodium falciparum causes the most severe form of the disease. The
immune response against Plasmodium spp. is complex and remains unclear. The present report aimed to better
understand the humoral immune response in severe malaria and analyse new immunodominant antigen can-
didates as possible serological marker in severe malaria in children.
This study included children aged 0–16 years from Guinea-Bissau with clinical signs of severe malaria.
Serological and immunochemical characterisation of diﬀerent anti-P. falciparum antibodies were made by ELISA
and immunoblotting using a crude protein extract of P. falciparum.
Sera from 12 children with severe malaria were analysed. Nine samples were positive for total anti-P. falci-
parum antibodies, seven for IgM and eight for total IgG anti-P. falciparum. There was a predominance of IgG1
response, suggesting a cytophilic action in severe malaria and a major role of IgG1 over other immunoglobulins.
The antigenic proﬁle of P. falciparum showed a consistent immunoblotting pattern of approximately 180 kDa,
100 kDa and around 50–40 kDa.
The serological reactivity found in protein bands makes them as immunodominant antigens and promising
candidates for serological markers in the context of severe malaria.
1. Introduction
Plasmodium falciparum causes the most serious form of the disease.
Infections with this parasite can be fatal in the absence of prompt re-
cognition of the disease, appropriate treatment and patient manage-
ment (Anon., 2012). The World Health Organization (WHO) have es-
tablished a set of clinical and laboratory criteria that deﬁnes severe
malaria (Anon., 2014).
Immunity seems to require humoral and cellular immune responses,
as the passive transfer of puriﬁed immunoglobulin (Ig) G from hyper-
immune sera to infected subjects has demonstrated that IgG mediates
anti-parasitic activity and overall protection against malaria (Cohen
et al., 1961). Also, a study of individuals from Ivory Coast and Burkina
Faso infected with P. falciparum demonstrated that a predominance of
IgG1 and IgG3 cytophilic antibodies was associated with protection
against the disease, whereas a predominance of IgG2 and IgG4 non-
cytophilic antibodies were related to an increased susceptibility to
malaria infection (Bouharoun-Tayoun and Druilhe, 1992). However,
the question about which cytophilic antibody is produced ﬁrst or which
one is more relevant remains unclear (Pinto et al., 2001).
On the other hand, IgM has been known to neutralize antigens very
eﬀectively, acting as part of an early immune response. Several studies
suggest that IgM has a protective role against malaria infection (Boudin
et al., 1993). For instance, IgM antibodies and mononuclear cells act
synergistically to inhibit the growth of P. falciparum in vitro more ef-
fectively than IgG (Brown et al., 1986). However, further evidence in-
dicates that the binding of IgM antibodies to the surface of infected
erythrocytes via the Fc receptor has a positive correlation with the
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formation of rosettes (Rowe et al., 2002; Ghumra et al., 2008), sug-
gesting a possible role of IgM in the severity of falciparum malaria.
The role of IgE antibodies in protection and/or pathogenesis is not
well established. Studies conducted in some islands of Burkina Faso and
in the frontiers of Thailand-Myanmar and Thailand – Cambodia in-
dicated that IgE may be related with the severity of malaria, as they
showed high levels of IgE in subjects with severe malaria (Calissano
et al., 2003). On the other hand, another study from a holoendemic area
of Tanzania, suggested that higher levels of malaria-speciﬁc IgE in
children were associated with a statistically signiﬁcantly reduced risk of
acute malaria (Bereczky et al., 2004).
The wide gap in understanding the biology of P. falciparum infection
makes diﬃcult to identify the most eﬀective vaccine candidate from
among the many of potential antigens of P. falciparum. The malaria
vaccines that present themselves as current candidates are directed
towards stages of the parasite's life cycle in humans and mosquitoes, but
until now, relatively few proteins have been studied towards devel-
oping a potential vaccine (Crompton et al., 2010). Nevertheless, a yet
large number of antigens have presented a major challenge towards the
identiﬁcation of the protective responses and their targets, and it may
be that eﬃcient immunity is mediated by responses to multiple anti-
gens.
Despite the global importance of P. falciparum, much work is yet to
be done regarding antigens characterisation. Therefore, the present
study aims to identify and characterise immunochemically the P. fal-
ciparum antigens involved in the induction and maintenance of humoral
immunity, in children with clinical signs of severe malaria caused by P.
falciparum.
2. Material and methods
2.1. Description of the studied population
This study included 12 children from 0 to 16 years old, with signs of
severe malaria or malaria requiring hospitalization due to oral intol-
erance. All the children included were clinically observed in the pae-
diatric consultations of the Hospital São José de Bor, in the village of
Bor, Bissau (Guinea-Bissau). The severe malaria diagnosis was assessed
through clinical evaluation and children fulﬁlling the following inclu-
sion criteria were enrolled: i) clinical diagnosis of severe malaria, ac-
cording to the clinical criteria established by WHO (2); ii) positive
microscopic examination. Children presenting the following medical
conditions were excluded: i) diarrhoea and severe dehydration; ii) se-
vere malnutrition; iii) pneumonia; iv) meningitis; v) encephalitis; vi)
tuberculosis; vi) diagnosed HIV infection.
An informed consent was applied to every participant and signed by
the parent or legal guardian. The participation of patients in the study
was voluntary. The study protocol was approved by the ethical com-
mittee (protocol number 3–2012-TM) of Instituto de Higiene e
Medicina Tropical, Lisbon, Portugal.
2.2. Samples collection
Blood samples were collected by venepuncture into heparin tubes.
Approximately 100 μl of total blood was absorbed in Whatman™ ﬁlter
paper (GE Healthcare, UK) and let dry at room temperature (RT). The
remaining sample was stored at −20 °C until needed.
2.3. Laboratorial conﬁrmation of Plasmodium falciparum infection
In order to conﬁrm the positive infection of malaria, rapid diag-
nostic test – RDT (Rapid Malaria pf/pan Antigen Test, Boson Biotech,
China), microscopic examinations and Polymerase Chain Reaction
(PCR) were performed. The RDT applied uses P. falciparum histidine-
rich protein 2 (HRP-2) and lactate dehydrogenase (LDH) and was per-
formed according to the supplier’s instructions.
Microscopic examination consisted on the visualization of thick
blood smears, ﬁxed with 10% methanol (v/v) for 1min, stained with
1% Giemsa’s solution (Merck, Germany) in Phosphate Buﬀered Saline
(PBS) (v/v) for 10min, washed with water and allowed to dry at RT.
Genomic DNA of P. falciparum was extracted using QIAamp DNA
Mini Kit (Quiagen, USA), according to manufacturer’s instructions.
DNA was afterwards ampliﬁed by nested-PCR, using primers designed
by Snounou et al. (1993), recognising the small subunit (18S) of ribo-
somal RNA gene, and synthesised by Thermo Scientiﬁc (Germany). For
PCR reactions the following reagents’ concentration was used: a) 10 x
NH4 buﬀer, 50mM MgCl, 100mM mixed dNTP, 100 pmol/μl of sense
and antisense primers; 5U/μl Taq polymerase, 3 μl DNA and water up to
50 μl. Ampliﬁcation conditions consisted of a) initial denaturation at
94 °C for 2min; b) denaturation at 94 °C for 0.30min; c) annealing at
55 °C for 1.30min; d) extension at 72 °C for 2min; repeat step b) to d)
for 40 times; e) ﬁnal extension at 72 °C for 10min. A negative control
(no template added) and a positive control (sample with infected blood)
were used. The ampliﬁed products were observed in 2% agarosis gel
(w/v).
2.4. Plasmodium falciparum parasites culture and total protein extraction
Cultures of Dd2 P. falciparum clones were developed in complete
RPMI 1640 culture medium with 5% haematocrit, 37 °C and an atmo-
sphere with 5% of CO2 as described in the work of Costa et al. (2013).
To extract P. falciparum proteins, parasite cultures were transferred to
15ml tubes, centrifuged at 2500g for 2min at RT and the supernatant
was discarded. Cells were suspended in lysis buﬀer (5 mM sodium
phosphate, pH 8+protease inhibitor [Complete Ultra Tablets, Roche,
Switzerland]), ﬁve times the pellet volume. The tubes were placed on
ice for 15min and then centrifuged at 18000g, at 4 °C for 20min. The
supernatant was discarded. The pellet was washed three times with ice
cold PBS. Every wash cycle comprised the addition of PBS and a cen-
trifugation at 18000g for 10min at 4 °C. The supernatant was discarded
at every wash cycle. The parasite lysis was accomplished with four
times the pellet volume of lysis buﬀer (0.1% Triton X-100 in
PBS+protease inhibitor [Complete ULTRA Tablets, Roche, Switzer-
land]). The tubes were placed on ice for 30min with gently shaking,
and homogenised by vortex every 10min. After, the tubes were placed
at −70 °C for 5min and then at 37 °C for 5min. This process was re-
peated two more times. After this cycle, the samples were centrifuged at
18000g for 10min at 4 °C. The supernatant was recovered and stored at
−20 °C. The quantiﬁcation of total protein of P. falciparum was per-
formed with Bicinchoninic Acid Protein kit (Sigma, USA), according to
the manufacturer’s protocol.
2.5. Serological measurement of anti-Plasmodium falciparum antibodies
Total antibodies (IgG+A+M), IgM, total IgG and its subclasses
and IgE were detected by enzyme-linked immunosorbent assay (ELISA)
using crude protein extract of P. falciparum to coat 96-well microplates
(Thermo Fisher Scientiﬁc, USA). The assay was developed according to
Costa’s protocol (Costa et al., 2013), with few changes: wells were
coated with 200 ng/well of crude protein extract of P. falciparum in
bicarbonate buﬀer (0.1 M, pH 8.5). The primary antibody was diluted
1/100, except when measuring total IgG, which was diluted 1/200. The
secondary antibody consisted of several diﬀerent antibodies (used in
separated assays), with diﬀerent dilutions, diﬀerent substrates and stop
solutions applied.
All samples were tested in duplicate and positive and negative
controls were used (adults with acute malaria and children without
stays in endemic areas of malaria, respectively). For the serological
measurement of IgE and IgG subclasses, neither positive nor negative
controls were used, for lack of truly representative control samples.
The cut-oﬀ was established as the mean of the negative controls plus
a stand-deviation (SD), obtained for the diﬀerent antibody analysed.
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The results were expressed in OD/cut-oﬀ to be compared between as-
says. Samples with OD/cut-oﬀ ratio above 1.1 were considered as po-
sitive and under 0.9 were considered to be negative for malaria anti-
bodies. Values in between 0.9 and 1.1 were repeated and, when the
result remained, were considered undetermined.
2.6. Characterisation of Plasmodium falciparum proteins by
immunoblotting
Western Blot was performed as described in Calisto (2015), using
23 ng/well of crude protein extract of P. falciparum. The primary anti-
body was diluted 1/100 (v/v) in antibody buﬀer (1% blocking buﬀer in
wash buﬀer). The determination of the protein’s molecular weight was
estimated by comparison with a 10–190 kDa commercial molecular
weight marker (HyperPAGE Prestained Protein Marker, Bioline, UK). As
negative controls, sera from subjects who have never been in malaria-
endemic areas were used. As positive controls, sera from patients in-
fected with P. falciparum were used.
2.7. Ethics approval and consent to participate
This study protocol was approved by the ethical committee of
Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa.
Lisbon, Portugal. Protocol number 3–2012-TM.
3. Results
In this study 12 children were included with a mean age of 6.75
years (SD=1.194); min=2, max= 14. The majority of the children
was female, representing 58% of patients (n=7). The clinical and la-
boratory results of the examination at admission are summarised in
Tables S1 and S2.
To conﬁrm the infection by P. falciparum, RDT, microscopy and PCR
were performed. The results are presented in Table 1. Eleven samples
were positive for P. falciparum in RDT and microscopy, but all the 12
samples were positive when tested by PCR. Children denominated of P3
and P5 showed a possible co-infection with P. falciparum and P. ma-
lariae according to the results obtained by RDT. The sample P11 was
weakly positive for P. malariae by RDT and it was the only sample that
was negative in microscopy. PCR was performed for the ampliﬁcation
of P. falciparum DNA and all samples were positive.
The levels of total antibodies (IgG+ IgA+ IgM), IgM, IgG and its
subclasses and IgE were determined in the twelve infected children with
severe malaria. The results are presented in Fig. 1A. From the twelve
samples, nine (75%) were positive for total anti-P. falciparum anti-
bodies, seven (58.3%) were positive for IgM, with one sample con-
sidered as undetermined. IgG anti-P. falciparum showed eight (66.7%)
positive samples (Table 2, Fig. 1A). The levels of total IgG were almost
always higher than IgM, except for sample P13. The levels of IgG
subclasses were assessed in the 12 Plasmodium-infected children, in
order to characterise the nature of the humoral response in the popu-
lation studied. A predominance of the cytophilic IgG1 response was
observed, with no serologic reactivity of any other subclasses (Error!
Reference source not found.1B). None of the samples tested was positive
for IgE antibody (Table 2).
The P. falciparum antigens responsible for the serological reactions
by ELISA assays were detected by immunoblotting. The antigenic pro-
ﬁle of the population studied is presented in Fig. 2. The analysis of the
antigens proﬁle of the samples from children with severe malaria
showed a consistent reactive pattern around the molecular weights of
Table 1
Laboratory conﬁrmation of malaria infection and results of serologic assays.
Samples Microscopy RDT PCR (P. falciparum) Total Abs (abs/cut-oﬀ) Total IgG (abs/cut-oﬀ) IgM (abs/cut-oﬀ) IgE (abs/cut-oﬀ)
P. malariae P. falciparum
P1 + − + + 11.05 12.77 6.12 0.004
P2 + − + + 2.22 3.47 0.68 0.001
P3 + + + + 7.56 8.23 3.28 0.006
P5 + + + + 0.69 0.25 0.76 0.001
P6 + − + + 2.19 3.47 1.03 0.002
P7 + − + + 0.37 0.36 0.54 0.001
P8 + − + + 13.46 14.20 4.86 0.005
P9 + − + + 8.37 7.77 4.84 0.003
P10 + − + + 5.56 7.39 3.02 0.001
P11 − +/−* − + 0.32 0.17 0.47 0.001
P12 + − + + 6.96 7.17 4.96 0.004
P13 + − + + 1.46 0.44 1.62 0.002
*Weakly positive.
Fig. 1. Serological levels of anti-Plasmodium falciparum antibodies, namely total
antibodies (IgG, IgA, IgM), total IgG, total IgM, IgG isotypes (IgG1, IgG2, IgG3,
IgG4), and IgE performed by indirect ELISA.
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190 kDa and 100 kDa (Error! Reference source not found.2, region 1
and 2). Notwithstanding, another (less relevant) pattern seems to
emerge in the molecular weight of approximately 50 kDa and 40 kDa
(Fig. 2, region 3).
Comparing the protein molecular weight marker with the most re-
active proteins obtained, it is possible to estimate potential P. falci-
parum antigens that were responsible for the IgG anti-P. falciparum
antibodies detected through ELISA. That analysis is presented in
Table 2.
4. Discussion
The present study aimed to characterise the mechanism of an early
humoral immune response of severe malaria, by serologic and antigenic
reactivity during the ﬁrst/former Plasmodium infections. The levels of
IgG measured indicated its importance for parasite control.
A group of 12 children from Bissau, Guinea-Bissau, with severe
malaria were included. Laboratorial diagnosis conﬁrmed the infection
with P. falciparum. Sample P11 may seem contradictory but several
explanations may exist: (i) sensitivity/speciﬁcity of the methods; (ii)
low parasite load; (iii) poor quality of the sample. Also, the poly-
morphism in the hrp-2 gene of P. falciparum may aﬀect the sensitivity of
the HRP-2 based RDT (Baker et al., 2010; Baker et al., 2005; Kumar
et al., 2012). For LDH, there is no polymorphism described, but the
detection of this antigen may fail due to the low sensitivity of the test in
cases of low parasitemia (Jang et al., 2013). Due to the higher sensi-
tivity and speciﬁcity of PCR regarding the other two methods, sample
P11 was still considered for further analyses (Mahende et al., 2016).
The results obtained by ELISA showed that the majority of the
children included have started developing the humoral response al-
ready. The three negative samples may correspond to recent infection,
with antibodies at undetectable levels in in vitro assays or with no time
to orchestrate the immune response.
Comparing the levels of those IgG and IgM antibodies, IgG antibody
was presented in higher levels than IgM, suggesting that IgG is im-
portant for parasite control, as indicated by Richards et al. (2010). Only
sample P13 had a higher level of IgM than IgG, indicating that child did
not develop a speciﬁc humoral response until blood collection.
In this present work, the mean age of the children with anti-malaria
antibodies was 9.4 years, and without anti-malaria antibodies was 4.5
years, allowing to speculate that older children can mount stronger
humoral responses, perhaps due to more exposures to the parasite in the
past. Analogous results were described in the study of Richards et al.
(2010).
The nature of the humoral response in severe P. falciparum malaria
seems to be characterised by a predominance of the cytophilic IgG1.
Pinto et al. also reported a dominance of cytophilic antibody rather
than non-cytophilic subclasses, when evaluating the response of IgG
subclasses anti-P. vivax in 34 children from 0 to 15 years old. In par-
ticular, patients showed a predominant IgG1 response, where 28 of
these children had never had any previous history of malaria and 6 had
one or two episodes of malaria (Pinto et al., 2001).
Since cytophilic antibodies are known to promote phagocytosis and
antibody-dependent cell-mediated cytotoxicity (ADCC) processes
(Bouharoun-Tayoun and Druilhe, 1992; Ferrante et al., 1990), the re-
sults of this present report suggest that these antibodies are involved in
opsonisation of infected red cells, as indicated elsewhere (Groux and
Gysin, 1990; Tebo et al., 2002). Furthermore, there is also evidence that
these subclasses antibodies act synergistically with monocytes through
antibody-dependent cellular inhibition (ADCI) processes, strongly in-
hibiting parasite growth (Theisen et al., 1998; Singh et al., 2005; Shi
et al., 1999; Tebo et al., 2001). There was no reactivity with the others
IgG subclasses studied, suggesting that they are not implicated in pro-
tective responses in severe malaria.
Regarding IgE anti-P. falciparum antibodies, all the twelve samples
were negative and unfortunately, no suggestions can be made con-
cerning the controversy between the protective role (Bereczky et al.,
2004; Duarte et al., 2007) or the contribution to the severity of malaria
(Calissano et al., 2003; Perlmann et al., 1994). As the use of biotine-
streptavidine complex increases the sensitivity of the technique, more
analyses could be performed to discard the possibility of IgE levels are
being underestimated. The conﬁrmation of the serological assays with a
larger sample size and with populations in diﬀerent stages of the dis-
ease would be useful to better understand the role of IgE in malaria.
The results obtained in ELISA assays are concordant with the re-
activity presented in immunoblotting. Almost all samples showed ser-
ologic reactivity, with the exception of P5, P7 and P11 that, similarly to
ELISA results, showed a very modest reaction in Western Blot or no
reactivity at all. These observations suggest that IgG is required for
protection against the parasite in severe cases of the disease. Similar
results were found in studies of immunoglobulin transfer of immune
donors to patients with acute P. falciparum malaria (Cohen et al., 1961).
The analysis of the antigens proﬁle of the samples from children
with severe malaria showed a consistent reactive pattern of approxi-
mately 100 kDa and 180 kDa. These results are similar to those obtained
in a study of 321 uninfected adults that showed IgG antibodies many
years after their last stay in endemic areas (Calisto, 2015). Notwith-
standing, another pattern seems to emerge between the molecular
Table 2
Potential P. falciparum antigens responsible for the positivity for total IgG antibodies. Only the most reactive protein bands in immunoblotting were considered.
Protein Mass (kDa) Representatively in the population studied (%) Potential antigen candidates References
182 67 MSP-1 precursor 175 K antigen Freeman and Holder (1983)
Camus and Hadley (1985)
97 83 96tR antigen Jouin et al. (1987)
50 58 51 kDa glycosylated antigen Epping et al. (1988)
42 59 MSP-1 (MSP1)42 Blackmann et al. (1991)
Fig. 2. Protein pattern of the reactivity detected by immunoblotting using
23 μg/well of Plasmodium falciparum crude extract. M: molecular weight marker
HyperPage (Bioline, UK). C-: negative control; C+: positive control.
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weights of 50–40 kDa, having similarities with a study of Costa and
colleagues with 227 adults with imported uncomplicated malaria
(Costa et al., 2013). It is interesting to notice that the antigenic re-
activity founded in the present report shares two diﬀerent patterns,
consistent with two diﬀerent populations.
The antigenic reactivity in P5 and P7 samples by immunoblotting
while negative in ELISA is probably the reﬂect of the higher sensitivity
and speciﬁcity of the immunoblotting over ELISA (Palaeya et al., 2013;
Cheong et al., 2013). However, we know that the sample population in
this study is reduced and therefore this information should be explored
in future studies. These results, though only suggestions towards the
identiﬁcation of proteins that reacted with IgG antibodies speciﬁc for P.
falciparum, can prove to be relevant in the development of new protein
targets as vaccine candidates.
Further in silico analysis of those antigens should be performed in
order to fully characterised them and use them in new serological
markers and/or vaccine designs. The knowledge of serological markers,
speciﬁcally in severe malaria, is important to understand the evolution
of the disease and avoid severity. The characterisation of the immune
response and the antigen candidates achieved with this work can be
useful to develop diagnostic tests in order to identify the severe stage of
malaria as well as new and more promising vaccine candidates.
On the other hand, we also understand the importance of in-
ﬂammation, lymphocytes migration and cytokines involved in the pa-
thogenesis of severe malaria, however we intend to evaluate these
components in future studies.
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